Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Expression of cortactin and focal adhesion kinase in colorectal adenocarcinoma: correlation with clinicopathologic parameters and their prognostic implication.

Kim YN, Choi JE, Bae JS, Jang KY, Chung MJ, Moon WS, Kang MJ, Lee DG, Park HS.

Korean J Pathol. 2012 Oct;46(5):454-62. doi: 10.4132/KoreanJPathol.2012.46.5.454. Epub 2012 Oct 25.

2.

Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma.

Cai JH, Zhao R, Zhu JW, Jin XL, Wan FJ, Liu K, Ji XP, Zhu YB, Zhu ZG.

J Gastrointest Surg. 2010 Aug;14(8):1248-57. doi: 10.1007/s11605-010-1247-2. Epub 2010 Jun 8.

PMID:
20532661
3.

Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy.

Rodrigo JP, Álvarez-Alija G, Menéndez ST, Mancebo G, Allonca E, García-Carracedo D, Fresno MF, Suárez C, García-Pedrero JM.

Cancer Prev Res (Phila). 2011 Aug;4(8):1333-41. doi: 10.1158/1940-6207.CAPR-10-0338. Epub 2011 Jun 6.

4.

Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients.

Theocharis SE, Kouraklis GP, Kakisis JD, Kanelli HG, Apostolakou FE, Karatzas GM, Koutselinis AS.

Eur J Surg Oncol. 2003 Sep;29(7):571-4.

PMID:
12943621
5.

Decreased expression of focal adhesion kinase is associated with a poor prognosis in extrahepatic bile duct carcinoma.

Hayashi A, Aishima S, Inoue T, Nakata K, Morimatsu K, Nagai E, Oda Y, Tanaka M, Tsuneyoshi M.

Hum Pathol. 2010 Jun;41(6):859-66. doi: 10.1016/j.humpath.2009.09.018. Epub 2010 Feb 25.

PMID:
20185162
6.

Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor.

Fujii T, Koshikawa K, Nomoto S, Okochi O, Kaneko T, Inoue S, Yatabe Y, Takeda S, Nakao A.

J Hepatol. 2004 Jul;41(1):104-11.

PMID:
15246215
7.

Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.

Itoh S, Maeda T, Shimada M, Aishima S, Shirabe K, Tanaka S, Maehara Y.

Clin Cancer Res. 2004 Apr 15;10(8):2812-7.

8.

Expression and clinical significance of FAK and Src proteins in human endometrial adenocarcinoma.

Chatzizacharias NA, Giaginis C, Gatzidou E, Tsourouflis G, Sfiniadakis I, Alexandrou P, Theocharis SE.

Pathol Oncol Res. 2011 Jun;17(2):277-85. doi: 10.1007/s12253-010-9310-6. Epub 2010 Nov 7.

PMID:
21058027
9.
10.

Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Giaginis CT, Vgenopoulou S, Tsourouflis GS, Politi EN, Kouraklis GP, Theocharis SE.

Pathol Oncol Res. 2009 Jun;15(2):173-81. doi: 10.1007/s12253-008-9120-2. Epub 2008 Nov 6.

PMID:
18987997
11.
12.

Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.

de Heer P, Koudijs MM, van de Velde CJ, Aalbers RI, Tollenaar RA, Putter H, Morreau J, van de Water B, Kuppen PJ.

Eur J Surg Oncol. 2008 Nov;34(11):1253-61. doi: 10.1016/j.ejso.2008.05.003. Epub 2008 Jun 16.

PMID:
18556171
13.

Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas.

Ayaki M, Komatsu K, Mukai M, Murata K, Kameyama M, Ishiguro S, Miyoshi J, Tatsuta M, Nakamura H.

Clin Cancer Res. 2001 Oct;7(10):3106-12.

14.

Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.

Canel M, Secades P, Rodrigo JP, Cabanillas R, Herrero A, Suarez C, Chiara MD.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3272-9.

15.

FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.

Theocharis S, Klijanienko J, Giaginis C, Alexandrou P, Patsouris E, Sastre-Garau X.

J Cancer Res Clin Oncol. 2012 Aug;138(8):1369-77. doi: 10.1007/s00432-012-1215-1. Epub 2012 Apr 10.

PMID:
22488171
16.

[Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].

Yuan Z, Fan J, Wu ZQ, Zhou J, Qiu SJ.

Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1256-9. Chinese.

PMID:
17686260
17.

Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.

Watanabe N, Takaoka M, Sakurama K, Tomono Y, Hatakeyama S, Ohmori O, Motoki T, Shirakawa Y, Yamatsuji T, Haisa M, Matsuoka J, Beer DG, Nagatsuka H, Tanaka N, Naomoto Y.

Clin Cancer Res. 2008 Jul 15;14(14):4631-9. doi: 10.1158/1078-0432.CCR-07-4755.

18.

Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ.

Hou H, Chen W, Zhao L, Zuo Q, Zhang G, Zhang X, Wang H, Gong H, Li X, Wang M, Wang Y, Li X.

J Clin Pathol. 2012 Dec;65(12):1088-96. doi: 10.1136/jclinpath-2012-200940. Epub 2012 Sep 3.

PMID:
22944623
19.

Clinical significance of focal adhesion kinase in resectable pancreatic cancer.

Furuyama K, Doi R, Mori T, Toyoda E, Ito D, Kami K, Koizumi M, Kida A, Kawaguchi Y, Fujimoto K.

World J Surg. 2006 Feb;30(2):219-26.

PMID:
16425085
20.

Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx.

Aronsohn MS, Brown HM, Hauptman G, Kornberg LJ.

Laryngoscope. 2003 Nov;113(11):1944-8.

PMID:
14603053

Supplemental Content

Support Center